| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0003 | 1 |